Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 690-692.

• Orginal Article • Previous Articles     Next Articles

Pharmaceutical Care of a Patient with Hydroxychloroquine Induced Long QT Syndrome

ZHAO Rui, CUI Xiangli, LIU Lihong*   

  1. Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2018-03-09 Revised:2019-01-09 Online:2018-11-20 Published:2019-01-09

Abstract: Objective To analyze pharmaceutical care on one case of long QT syndrome(LQTS) induced by hydroxychloroquine (HCQ) sulfate tablets, so as to provide reference to the clinical safe medication. Methods By collecting the correlative papers and analyzing clinical drug use, we analyzed the correlation between the prescriptions and LQTS. Results HCQ has a significant correlation with LQTS, it induced prolongation of the QT interval and torsades de pointes(TdP). Conclusion HCQ is a drug with conditional TdP risk. We should pay attention to clinical medication and measures to prevent and deal with similar ADR.

Key words: hydroxychloroquine(HCQ), adverse drug reaction(ADR), long QT syndrome

CLC Number: